Get the Daily Brief
Latest Biotech News
Advancements in Nursing: Intelligent Frameworks and Patient-Centered Care
Recent research highlights innovative developments in nursing care methodology. One study introduces a digital intelligent precise nursing framework designed to enhance patient outcomes through...
Emerging Research on Depression Mechanisms and Mental Health Pathways
Groundbreaking studies have identified novel molecular mechanisms underlying depression and its connection to brain biochemistry. One pivotal study reveals that abnormal sugar protein...
Nobel Prize Awarded for Peripheral Immune Tolerance Discoveries
The 2025 Nobel Prize in Physiology or Medicine has been awarded jointly to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their seminal work on peripheral immune tolerance. Their...
CareDx Achieves IVDR Certification Advancing Transplant Diagnostics
CareDx has secured IVDR certification from the European Union for its AlloSeq Tx and QType next-generation sequencing and RT-PCR-based HLA typing products. These platforms enhance compatibility...
Skye Bioscience’s CB1 Antibody Fails Obesity Trial, Shares Plunge
Skye Bioscience announced the failure of its obesity drug nimacimab—an antibody targeting cannabinoid receptor 1 (CB1)—to achieve significant weight loss in a phase 2 trial. Nimacimab monotherapy...
Algen Biotechnologies and AstraZeneca Forge $555M AI-Driven Immunology Pact
Algen Biotechnologies and AstraZeneca announced a drug discovery partnership valued at up to $555 million. The collaboration leverages Algen's AlgenBrain platform, which integrates single-cell...
Regencell Bioscience’s Stock Soars Amid Retail Frenzy, Then Crashes
Regencell Bioscience Holdings, a Hong Kong-based early-stage biotech focused on traditional Chinese medicine for neurocognitive disorders, experienced extraordinary stock volatility in 2025....
Cancer Research: New Mechanisms in Breast and Colorectal Oncology Revealed
Recent studies have identified key molecular drivers in major cancers. Research on colorectal cancer reveals that loss of the HUWE1 ubiquitin ligase promotes stemness and drug resistance by...
Advances in Pediatric Clinical Research and Neonatal Care
Several pivotal pediatric health developments surface. A novel clinical tool dramatically improves pediatricians' adherence to peanut allergy prevention guidelines by a factor of 15, heralding a...
Cytiva’s Global Biopharma Index Reveals Talent Crunch, Regulatory Challenges
Cytiva’s 2025 Global Biopharma Index highlights declining ecosystem resilience with an average score dip to 5.96 from 6.08 in 2023. The report notes improved supply chain robustness but continuing...
Advances in Computational Biology and Machine Learning for Drug Discovery
Breakthroughs in computational biology drive new frontiers in drug discovery and protein design. The DeepMice model introduces multilevel mapping to optimize protein-ligand docking, improving...
Pfizer’s Deal with US Administration Spurs Stock Surge and Manufacturing Pledge
Pfizer’s accord with the Trump administration, securing a three-year tariff grace period amid commitments to expand U.S. manufacturing and apply most favored nation (MFN) pricing to Medicaid...
Aerska Emerges with $21 Million to Develop RNAi Neurological Therapies
Dublin-based biotech Aerska recently secured $21 million in a financing round led by Age1, Backed VC, and Speedinvest to advance its RNA interference (RNAi) therapeutics. The company focuses on...
AstraZeneca and Daiichi Sankyo Report Phase 3 Success for Datroway in Triple Negative Breast Cancer
AstraZeneca and Daiichi Sankyo announced positive data from a registrational Phase 3 study of Datroway, a next-generation drug succeeding Enhertu, in triple-negative breast cancer (TNBC). This...
Trogenix Raises $95 Million Series A to Advance Brain Cancer Trojan Horse Therapy
Trogenix has raised $95 million in a Series A financing round to push forward its innovative "Trojan horse" modality aimed at treating brain cancer, starting with glioblastoma. The capital...
FDA Launches Pilot for Accelerated Review of U.S.-Made Generic Drugs
The U.S. Food and Drug Administration (FDA) announced a pilot program to expedite regulatory review of generic drugs that are both tested and manufactured domestically with U.S.-sourced active...
Ignota Labs Acquires Kronos Bio Pipeline to Revive Shelved Drug Candidates
Ignota Labs has acquired the clinical pipeline of Kronos Bio following setbacks that led to Kronos’s departure from public markets. This acquisition underlines Ignota's innovative approach to...
Pfizer’s Deal with Trump Spurs Stock Rally and US Manufacturing Boost
Pfizer secured a three-year exemption from planned 100% tariffs under a deal with the Trump administration, agreeing to expand U.S. manufacturing and implement 'most favored nation' Medicaid...
Researchers Unveil T Cell Engagers as Next-Gen Autoimmune Therapy
Emerging data present T cell engagers as a promising biologic class capable of inducing 'immune reset' for autoimmune diseases by selectively eliminating autoreactive B cells and plasma cells....
Breakthrough Model DeepMice Optimizes Protein-Ligand Docking for Drug Discovery
Researchers have introduced DeepMice, an innovative protein-ligand molecular docking model employing advanced multilevel mapping to enhance accuracy and efficiency in drug discovery. This...